Thirty-one percent of participants with schizophrenia spectrum disorders installed app; app remained installed in 70 percent <\/em><\/p>\n<\/h3>\n <\/b><\/p>\n <\/b><\/p>\n WEDNESDAY, July 28, 2021 (HealthDay News) — Acceptability of a passive smartphone-based ecological momentary assessment (EMA) app is relatively low among individuals with schizophrenia spectrum disorders, according to a study published in the July issue of the Journal of Medical Internet Research<\/em>.<\/p>\n Javier-David Lopez-Morinigo, M.D., Ph.D., from IIS-Fundaci \u00b3n Diaz in Madrid, and colleagues examined the acceptability of a passive smartphone-based EMA app, evidence-based behavior (eB2), among patients with schizophrenia spectrum disorders, aged 18 to 64 years, who did not receive financial compensation.<\/p>\n Twenty-four of the 77 participants consented to install the eB2 app; for 70 percent of these (14 participants), the app remained installed until the end of the study (median follow-up, 14.5 weeks). The researchers found that compared with nonusers, users were younger and had a higher education level, better premorbid adjustment, better executive function, and higher cognitive insight levels in a univariate analysis. In a multivariable regression model, only age and early adolescence premorbid adjustment remained significant (adjusted odds ratios, 0.93 and 0.75, respectively), predicting eB2 acceptability.<\/p>\n “Our findings do reflect the extent to which real-world patients with schizophrenia spectrum disorder consented to a mobile-based EMA app, and what appears to underlie this, regardless of the potential financial incentives. Specifically, the vast majority (31\/53, 59 percent) of those who refused to install eB2 reported lack of interest,” the authors write. “Although a financial incentive may have reduced the proportion of nonusers, this would have not reflected a real patient involvement in using EMA.”<\/p>\n Two authors cofounded the evidence-based behavior app.<\/p>\n